BBOX1 and cancer: In pathway network analyses, BBOX1 was linked to ‘lysine degradation’, ‘monocarboxylic acid catabolic process’, ‘T‐cell antigen receptor signaling pathway’, ‘cancer immunotherapy by PD‐1 blockades’, and ‘antigen processing and presentation’.